Sector: Healthcare

In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.

There seems to be no end to the cannabis sector’s woes. Several prominent cannabis players reported disappointing results in the latest earnings season.

On Thursday, Berkshire Hathaway (BRK.B) (BRK.A) released its third-quarter 13F. There were some surprises in the filing. The company took a new stake in RH.

Charlotte’s Web Holdings reported its fiscal 2019 third-quarter earnings results on November 13. Its revenue came in at $25.1 million.

Wellington Management filed its 13F on Wednesday. Based on the filing, the market value of total publicly traded securities was around $443.45 billion.

After Charlotte’s Web reported its Q3 earnings yesterday, it closed at 12.28 Canadian dollars on the TSE, 7.53% lower than its previous closing price.

Alphabet stock closed 0.08% lower yesterday after news of privacy concerns about Google's healthcare initiative, Project Nightingale.

At the end of the third quarter, Bristol-Myers Squibb, Celgene, Biogen, UnitedHealth, and Walmart (WMT) were Renaissance Technologies' top five buys.

After falling for the first two days this week, the cannabis sector maintained that weakness today. Let's look at some cannabis stocks that are in the news.

Canopy Growth is set to report its second-quarter earnings results on November 14. In the first two days of trading this week, it's fallen 11.5%.